Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
High Growth Tech Stocks to Watch in February 2025

In This Article:

As global markets navigate a complex landscape marked by fluctuating economic indicators and competitive pressures in the technology sector, investors are closely watching key indices like the Nasdaq Composite, which recently experienced significant volatility due to emerging AI developments. In this environment, identifying promising high-growth tech stocks involves assessing companies that can effectively leverage innovation and adapt to shifting market dynamics while maintaining robust earnings potential.

Top 10 High Growth Tech Companies

Name

Revenue Growth

Earnings Growth

Growth Rating

Shanghai Baosight SoftwareLtd

21.82%

25.22%

★★★★★★

Seojin SystemLtd

35.41%

39.86%

★★★★★★

Clinuvel Pharmaceuticals

21.39%

26.17%

★★★★★★

Ascelia Pharma

76.15%

47.16%

★★★★★★

Medley

20.95%

27.32%

★★★★★★

TG Therapeutics

29.48%

43.58%

★★★★★★

Fine M-TecLTD

36.52%

135.02%

★★★★★★

Initiator Pharma

73.95%

31.67%

★★★★★★

Dmall

29.53%

88.37%

★★★★★★

Delton Technology (Guangzhou)

20.25%

29.52%

★★★★★★

Click here to see the full list of 1230 stocks from our High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Bonesupport Holding

Simply Wall St Growth Rating: ★★★★★★

Overview: Bonesupport Holding AB (publ) is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK22.93 billion.

Operations: The company generates revenue primarily from its pharmaceuticals segment, which contributed SEK814.46 million.

Bonesupport Holding AB, a company in the high-growth tech sector, is showcasing robust potential with its innovative CERAMENT products. Recent clinical studies have demonstrated significant advantages of CERAMENT in treating bone infections, leading to a remarkable increase in 5-year survival rates for patients compared to standard treatments. Financially, BONEX is outpacing industry growth with an annual revenue increase projected at 33.8% and earnings expected to surge by 73.1% annually. This performance starkly contrasts the broader Swedish market's growth rates of just 1.1% for revenue and 13.4% for earnings per year, positioning Bonesupport well above average forecasts and highlighting its strong market presence driven by pioneering medical solutions.

OM:BONEX Earnings and Revenue Growth as at Feb 2025
OM:BONEX Earnings and Revenue Growth as at Feb 2025

Zhejiang Huace Film & TV

Simply Wall St Growth Rating: ★★★★★☆

Overview: Zhejiang Huace Film & TV Co., Ltd. is involved in the production, distribution, and derivative of film and television dramas both in China and internationally, with a market capitalization of CN¥14.15 billion.